Invention Grant
- Patent Title: Ionizable cationic lipids
-
Application No.: US16983121Application Date: 2020-08-03
-
Publication No.: US11999675B2Publication Date: 2024-06-04
- Inventor: Frank DeRosa , Braydon Charles Guild , Michael Heartlein
- Applicant: Translate Bio, Inc.
- Applicant Address: US MA Lexington
- Assignee: TRANSLATE BIO, INC.
- Current Assignee: TRANSLATE BIO, INC.
- Current Assignee Address: US MA Waltham
- Agency: LATHROP GPM LLP
- Agent James H. Velema, Esq.
- Main IPC: A61K47/00
- IPC: A61K47/00 ; A61K9/127 ; A61K9/50 ; A61K38/18 ; A61K38/47 ; A61K48/00 ; C07C211/21 ; C12N15/85

Abstract:
Disclosed herein are novel compounds, pharmaceutical compositions comprising such compounds and related methods of their use. The compounds described herein are useful, e.g., as liposomal delivery vehicles to facilitate the delivery of encapsulated polynucleotides to target cells and subsequent transfection of said target cells, and in certain embodiments are characterized as having one or more properties that afford such compounds advantages relative to other similarly classified lipids.
Public/Granted literature
- US20210009503A1 IONIZABLE CATIONIC LIPIDS Public/Granted day:2021-01-14
Information query